Literature DB >> 11802809

Maintenance and characterization of an Epstein Barr virus-infected CD56-negative T cell lymphoma.

Izuru Maekawa1, Hitoshi Satoh, Naoto Aoki, Yasuyuki Morishita, Norifumi Tsukamoto, Masamitsu Karasawa, Yasunobu Nonaka, Mami Shiota, Yoshihisa Nojima, Shigeo Mori.   

Abstract

T cell lymphoma carrying Epstein Barr virus (EBV(+) TL) is very rare among Western countries while it is much more common among Japanese. Here we report an EBV(+) TL which has been maintained for years by the use of mice with severe combined immune deficiency (SCID) mice. Lymphoma was obtained from a 55-year-old male suffering from oculomotor nerve palsy and lymphadenopathy. A small piece of biopsied tumor was transplanted into SCID mice and the lymphoma has been maintained for over 3 years with passages every 2 - 3 weeks. The maintained lymphoma, termed as TMS24, and the original lymphoma cells showed identical phenotype and genotype, including diffuse medium-sized cell morphology lacking granules, suppressor / cytotoxic immunophenotype and identical T cell receptor beta-chain gene rearrangement mode. Further, both were shown to carry an identical EBV clone in terms of the number of terminal repeats and the latency II-type restricted gene expression profile. Cytogenetically, TMS24 retained two characteristic chromosomal translocations of t(1;18)(q32;q21) and t(6;12)(p21;q24). Since only one cell line with such characters has been reported previously, TMS24 should be useful for detailed analysis of EBV(+) TL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802809      PMCID: PMC5926862          DOI: 10.1111/j.1349-7006.2002.tb01201.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  37 in total

1.  Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.

Authors:  M Rowe; A L Lear; D Croom-Carter; A H Davies; A B Rickinson
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 2.  EBV-NK cells interactions and lymphoproliferative disorders.

Authors:  H Kanegane; A Yachie; T Miyawaki; G Tosato
Journal:  Leuk Lymphoma       Date:  1998-05

3.  A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene.

Authors:  T Akasaka; I Miura; N Takahashi; H Akasaka; N Yonetani; H Ohno; S Fukuhara; M Okuma
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

4.  Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridisation.

Authors:  S J Hamilton-Dutoit; G Pallesen; J Karkov; P Skinhøj; M B Franzmann; C Pedersen
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

Review 5.  Jumping translocations of 11q in acute myeloid leukemia and 1q in follicular lymphoma.

Authors:  Y S Fan; K Rizkalla; B F William; C J Engel
Journal:  Cancer Genet Cytogenet       Date:  2000-04-01

Review 6.  Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Authors:  J K Chan; V C Sin; K F Wong; C S Ng; W Y Tsang; C H Chan; M M Cheung; W H Lau
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

7.  Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency.

Authors:  T Itoh; M Shiota; M Takanashi; I Hojo; H Satoh; A Matsuzawa; T Moriyama; T Watanabe; K Hirai; S Mori
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

8.  High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.

Authors:  Y Sasajima; H Yamabe; Y Kobashi; K Hirai; S Mori
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma.

Authors:  A L Cheng; I J Su; Y C Chen; W C Uen; C H Wang
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.